Santa Clara, CA – According to filings with the U.S. Securities and Exchange Commission, Ancora Heart is raising $80,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Jeffrey Closs played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Ancora Heart
Ancora Heart is a medical device company dedicated to providing new treatment options for people with heart failure (HF). The companys proprietary AccuCinch Ventricular Restoration System is the first completely percutaneous device designed to restore the enlarged left ventricle of the heart, thereby addressing the fundamental issue in the progression of systolic heart failure.

To learn more about Ancora Heart, visit http://www.ancoraheart.com/

Contact:
Jeffrey Closs, President and Chief Executive Officer
408-727-1105
jcloss@ancoraheart.com
https://www.linkedin.com/in/jeffcloss/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved